spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  human growth hormone 

 HSMN NewsFeed - 25 Dec 2017
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Feb 2016
Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 26 Jan 2016
Antares Pharma Announces CEO Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2015
Antares Pharma Announces FDA Approval of Sumatriptan Injection USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jul 2015
Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2014
Versartis Appoints Endocrinologist Bert Bakker, MD, PhD, as Senior Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 18 Feb 2014
Versartis Secures $55 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 19 Nov 2013
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2013
Jade Therapeutics Elects Veteran Life Science Entrepreneur Dinesh Patel, Ph.D., to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 15 Jan 2013
Versartis Closes $25 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Nov 2012
Antares Pharma Announces Positive Results from Final MTX Medi-Jet(TM) Clinical Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 4 Aug 2011
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Apr 2011
Antares Pharma Announces FDA Acceptance of Anturol(R) NDA for Filing
Biopharmaceuticals Urology
 HSMN NewsFeed - 16 Feb 2011
Versartis Completes $21 Million Series B Financing
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 3 Feb 2011
Theratechnologies and Ferrer Announce a Distribution & Licensing Agreement for Tesamorelin in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 1 Dec 2010
Theratechnologies Welcomes the Arrival of Its New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jul 2010
Phage Pharmaceuticals Appoints David Jackson as Vice President, Operations Planning
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2010
ARIAD Names Timothy P. Clackson to New Position of President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2010
Paul Westberg Joins Versartis as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
Antares Pharma Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of Anturol for the Treatment of Overactive Bladder
Biopharmaceuticals Urology Drug Delivery
 HSMN NewsFeed - 20 Jan 2010
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jan 2010
Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Application
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 8 Jul 2009
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2009
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Sep 2008
Teva Receives EU Marketing Authorization for TevaGrastim(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Jun 2008
Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles
Biopharmaceuticals Generics
 HSMN NewsFeed - 26 Feb 2008
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2008
Cook Pharmica Names Fred Larimore, Ph.D., Vice President of Scientific Affairs, CSO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2008
ARIAD Appoints Richard W. Pascoe as Chief Operating Officer and Expands Role of Timothy P. Clackson, Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
Teva to Acquire CoGenesys
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Nov 2007
Pfizer and Nektar Reach Agreement on Exubera(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 17 Aug 2007
Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Jul 2007
Ambrx Appoints Stephen Kaldor Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2007
Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2007
Emisphere Technologies, Inc. Appoints Laura Kragie as Vice President of Clinical Development/Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Apr 2007
Pharmacia Subsidiaries Reach $34.7 Million Settlement with DOJ; Resolve Allegations of Improper Activities Prior to Acquisition by Pfizer
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Mar 2007
Cangene receives an approvable letter from the FDA for human growth hormone
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2007
Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 30 Jan 2007
Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 16 Jan 2007
Emisphere Announces Executive Management Changes
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 20 Dec 2006
Altus Pharmaceuticals Enters into Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Products for Growth Hormone Deficient Patients
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Dec 2006
Altus Pharmaceuticals Appoints Bruce A. Leicher General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Nov 2006
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2006
GenSci Expects Topical Molgramostim Gel Approval in 2007
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 23 Jun 2006
Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-Per-Week Growth Hormone
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 77

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 77 additional stories matching:
human growth hormone
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.